Ireland - English - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - pethidine hydrochloride - solution for injection - 100/2 milligram(s)/millilitre - phenylpiperidine derivatives; pethidine

Ireland - English - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - pethidine hydrochloride - solution for injection - 50 milligram(s)/millilitre - phenylpiperidine derivatives; pethidine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - pethidine hydrochloride - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - pethidine hydrochloride - solution for injection - 50mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: sodium chloride; water for injections - leucovorin calcium injection usp is indicated following high dose methotrexate therapy to reduce toxicity (leucovorin rescue). it is also indicated after inadvertent overdosage with methotrexate and in impaired methotrexate elimination.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma (m) sdn. bhd. - pethidine hydrochloride -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma (m) sdn. bhd. - pethidine hydrochloride -

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - pethidine hydrochloride - solution for injection - 50 milligram(s)/millilitre - phenylpiperidine derivatives; pethidine

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius kabi malaysia sdn. bhd - pethidine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - pethidine hydrochloride, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - indications as at 18 may 2020: 1. the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. 2. pre-operative medication. 3. analgesic adjunct in general anaesthesia. 4. obstetric analgesia.